Abstract
Several clinicopathologic studies of primary mediastinal large B-cell lymphoma (Med-DLBCL) have been reported from Western countries; however, only a few series of at most 10 cases are available in Japan. To further clarify the Med-DLBCL occurring in Japan, we analyzed the clinical features of 28 patients with Med-DLBCL diagnoses who were treated at the National Cancer Center Hospital between 1982 and 2002. The median age was 37 years (range, 18-80 years). The ages of 16 male patients ranged widely from 18 to 80 years, whereas the 12 female patients appeared to show a single age peak at 20 to 40 years. Only 13 patients (46%) achieved a complete response with initial treatments, mostly by CHOP-like regimens (cyclophosphamide, doxorubicin, vincristine [Oncovin], and prednisolone) followed by radiotherapy. The estimated 3-year overall and failure-free survival rates were 32% and 33%, respectively, indicating the relatively unfavorable prognosis of the patients in our series. The following factors were found to be significantly associated with shortened survival prospects: age >60 years, serum lactate dehydrogenase level greater than normal, performance status >1, and presence of bulky mediastinal mass. In conclusion, the clinical ...Continue Reading
References
May 1, 1985·Annals of Internal Medicine·P Klimo, J M Connors
Sep 1, 1989·The American Journal of Surgical Pathology·L LamarreN L Harris
Oct 1, 1989·American Journal of Clinical Oncology·C HaiounF Reyes
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Jan 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M ShimoyamaS Tominaga
Nov 1, 1988·Cancer·J O JacobsonN L Harris
Sep 1, 1983·Human Pathology·M E KadinH Wakasa
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Apr 1, 1995·British Journal of Haematology·B FaliniL Pasqualucci
Dec 1, 1994·Histopathology·J K ChanP G Isaacson
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN International Non-Hodgkin's Lymphoma Prognostic Factors Project
Jul 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D KirnG P Canellos
Jul 1, 1996·The American Journal of Surgical Pathology·D Cazals-HatemJ Audouin
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M LazzarinoP Möller
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U PopatK van Besien
Jul 29, 1998·Medical and Pediatric Oncology·H C TohP T Ang
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Sep 18, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J R AndersonD D Weisenburger
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A Abou-ElellaJ O Armitage
Oct 8, 1999·Leukemia & Lymphoma·S BieriF Cavalli
Sep 30, 2000·Pathology International
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K van BesienP Bahaguna
Oct 12, 2001·International Journal of Hematology·N YonetaniH Ohno
May 31, 2003·International Journal of Hematology·Izidore S Lossos, Ronald Levy
Aug 23, 2003·Blood·Kerry J SavageMargaret A Shipp
Sep 17, 2003·The Journal of Experimental Medicine·Andreas RosenwaldLouis M Staudt
Citations
Oct 15, 2008·Annals of Hematology·T FietzUNKNOWN East German Study Group on Hematology and Oncology-OSHO
Mar 4, 2010·International Journal of Hematology·Hee Kyung AhnWon Seog Kim
Jan 1, 2009·BMJ Case Reports·Abdul Majid WaniMazen G Bafaraj
Jun 8, 2006·International Journal of Hematology·Slobodanka Ostojić KolonićBranimir Jaksić
Mar 25, 2015·Journal of the Chinese Medical Association : JCMA·Sheng-Hsiang YangCheng-Hwai Tzeng
Aug 8, 2012·Leukemia Research·Katsuya YamamotoHironobu Minami
Apr 12, 2014·Blood Research·Heui June AhnCheolwon Suh
Mar 15, 2005·Clinical Nuclear Medicine·Veronica SolisRichard P Spencer